Tesamorelin / Ipamorelin Blend
GHRH analogue plus secretagogue for fat loss and lean mass.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About Tesamorelin / Ipamorelin Blend
This blend combines Tesamorelin, a potent GHRH analogue with strong evidence for reducing visceral fat, with Ipamorelin, a selective GH secretagogue. Together they drive a robust GH response aimed at body recomposition — targeting stubborn fat while supporting lean mass and recovery.
Key Benefits
- Targets visceral fat via GHRH pathway
- Adds selective GH secretagogue synergy
- Supports lean body composition
- Improves recovery and sleep quality
Set a goal (top of the page) to see how Tesamorelin / Ipamorelin Blend scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- Water retention
- Injection site reactions
- Joint aches
- Flushing
Legal & Regulatory Status
Research use only. Not FDA-approved. No studies exist on this specific combination; the evidence reflects the components (tesamorelin — approved only for HIV-lipodystrophy visceral fat; ipamorelin — limited human GH-PK data).
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
No citations available. We could not locate indexed peer-reviewed literature for this compound specifically. That absence is the reason for its evidence rating — treat any claims about it, including ours, with corresponding caution.